Operating cash flow of $47.0B in 2026Q2 was 2.23 times net income, but aggressive capex (41.8% of revenue) drove free cash flow to -$32.8B, indicating a heavy reinvestment phase.
ASE Technology Holding Co., Ltd. (ASX) cash flow statement — 27-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 |
|---|
| Cash from Operations | 330.06B | 143.03B | 84.74B | 104.56B | 105.21B | 78.79B | 69.52B | 65.46B | 51.68B | 47.27B | 51.19B | 55.36B | 45.65B | 40.58B | 32.58B | 32.17B | 34.36B | 15.55B | 30.69B | 28.08B | 34.64B | 20.97B | 18.73B | 13.29B | 11.34B | 11.71B | 17.64B | 7.73B |
| Operating CF Margin % | - | 22.04% | 13.94% | 18.21% | 15.49% | 13.96% | 15.28% | 16.02% | 13.67% | 16.41% | 18.57% | 18.84% | 17.55% | 18.74% | 17.02% | 16.97% | 19.62% | 18.66% | 31.41% | 28.02% | 34.37% | 24.35% | 25.9% | 23.22% | 24.82% | 30.51% | 34.67% | 23.27% |
| Operating CF Growth % | 1233.35% | 68.79% | -18.96% | -0.62% | 33.54% | 13.32% | 6.21% | 26.67% | 9.33% | -7.67% | -7.52% | 21.26% | 12.49% | 24.57% | 1.28% | -6.37% | 120.96% | -49.34% | 9.3% | -18.93% | 65.2% | 11.96% | 40.88% | 17.21% | -3.13% | -33.64% | 128.37% | - |
| Net Income | 61.08B | 40.66B | 33.15B | 31.3B | 62.86B | 63.29B | 26.33B | 16.66B | 25.73B | 22.8B | 21.74B | 20.2B | 23.96B | 15.45B | 12.9B | 14.04B | 17.01B | 6.55B | 6.37B | 12.05B | 17.82B | -5.17B | 3.53B | 2.74B | 129.36M | -2.14B | 5.84B | 7.93B |
| Depreciation & Amortization | 56.27B | 67.44B | 59.95B | 56.25B | 55.01B | 53.25B | 48.37B | 49.32B | 43.09B | 28.84B | 29.5B | 30.61B | 26.71B | 25.08B | 23.13B | 23.47B | 18.42B | 17.14B | 17.84B | 16.47B | 14.54B | 15.95B | 15.05B | 13.57B | 13.13B | 11.82B | 9.15B | 6.17B |
| Stock-Based Compensation | 338.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 565.43M | 470.95M | 51.72M | 223.2M | 725.98M | 2.01B | 483.6M | -493.43M | -1.6B | -1.19B | -1.13B | -401.75M | -226.89M | -349.32M |
| Other Non-Cash Items | 264.9B | 11.58B | -2.78B | -2.07B | 12.18B | -6.82B | 2.15B | -777.68M | -3.8B | 1.85B | 5.89B | 2.68B | 3.77B | 3.33B | 1.68B | 2.25B | 1.28B | 505.72M | 2.21B | 3.29B | -800.07M | 9.52B | 5.31B | 211.44M | 66.02M | -473.53M | -682.22M | -4.42B |
| Working Capital Changes | -46.9B | 23.35B | -5.59B | 19.08B | -24.84B | -30.94B | -7.32B | 261.8M | -13.35B | -6.23B | -5.94B | 1.87B | -8.79B | -3.28B | -5.7B | -8.07B | -2.4B | -8.87B | 3.53B | -5.74B | 2.59B | 1.15B | -3.57B | -2.84B | -1.21B | 337.73M | -93.54M | -1.61B |
| Change in Receivables | -45.38B | -13.05B | -14.09B | 16.62B | -1.34B | -29.37B | -8.64B | -419M | -9.55B | -4.36B | -6.41B | 8.33B | -9.84B | -5.69B | -6.35B | 1.17B | -1.73B | -6.41B | 7.96B | -5.48B | 4.78B | -2.71B | -1.12B | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -26.17B | -8.56B | 1.82B | 25.06B | -21.94B | -23.1B | -12.94B | 1.39B | -9.42B | -2.88B | 3.17B | -5.32B | -8.32B | -3.19B | -2.4B | -5.22B | -2.01B | -1.47B | 151.69M | -314.58M | 1.37B | 89.49M | -4.51B | -1.56B | -364.07M | 477.9M | -796.62M | -452.85M |
| Change in Payables | 30.02B | 10.56B | 7.85B | -8.92B | -5.52B | 13.52B | 13.39B | -1.01B | 7.12B | 4.71B | 1.67B | -1.32B | 6.51B | 4.65B | 2.95B | -3.27B | 1.54B | 3.68B | -4.5B | 655.1M | -3.69B | 3.21B | 1.43B | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -583.2B | -166.55B | -86.53B | -54.87B | -75.98B | -54.95B | -64.15B | -65.95B | -141.15B | -16.2B | -46.35B | -56.45B | -29.3B | -29.5B | -43.29B | -32.76B | -33.47B | -15.53B | -37.62B | -17.94B | -22.18B | -13.81B | -29.62B | -18.55B | -13.2B | -15.18B | -33.55B | -12.57B |
| Capital Expenditures | -571.8B | -162.15B | -83.86B | -54.16B | -74.88B | -73.63B | -61.55B | -58.07B | -44.76B | -25B | -27.3B | -31.91B | -40.54B | -29.01B | -38.97B | -31.28B | -31.85B | -11.12B | -19.33B | -17.7B | -18.01B | -16.09B | -27.41B | -17.52B | -12.69B | -11.57B | -30.06B | -10.05B |
| CapEx % of Revenue | 80.01% | 24.99% | 13.8% | 9.43% | 11.03% | 13.04% | 13.53% | 14.21% | 11.84% | 8.68% | 9.91% | 10.86% | 15.59% | 13.4% | 20.35% | 16.5% | 18.19% | 13.34% | 19.79% | 17.66% | 17.87% | 18.69% | 37.91% | 30.59% | 27.77% | 30.14% | 59.07% | 30.26% |
| Acquisitions | -944.62M | 0 | -1.62B | 849.06M | -362.67M | 19.06B | -6B | -11.62B | -105.06B | 8.19B | -2.47B | 9.49B | 10.47B | 99.62M | 220.32M | -832.84M | -5.49B | 90.47M | -27.21B | -494.64M | 414.98M | 1.74B | -629.1M | -20.95M | -2.09B | 0 | 0 | -7.4B |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -10.19B | -4.4B | -1.2B | 216.4M | -531.13M | -242.63M | 1.2B | 26.75M | 2.55B | 268.7M | -1.42B | -281K | -487.24M | -98.46M | -687.82M | -731.86M | -4.38M | -1B | -367.17M | -683.5M | 4.91B | 1.68B | -1.4B | -768.52M | -1.04B | -484.23M | 10.56M | 4.88B |
| Cash from Financing | 277.38B | 45.52B | -6.53B | -47.97B | -62.11B | 524.22M | -14.98B | 5.56B | 93.85B | -18.92B | -18.07B | -284.13M | -12.88B | 11.6B | 7.55B | -350.48M | 1.58B | -2.7B | 14.34B | -8.41B | -12.6B | -101.74M | 8.81B | 4.21B | 531.76M | 603.5M | 17.58B | 8.72B |
| Debt Issued (Net) | 90.31B | 67.41B | 16.83B | -10.67B | -31.57B | 22.13B | -7.9B | 15.56B | 103.55B | -19.48B | -7.01B | 19.61B | -4.29B | 15.04B | 7.88B | 5.88B | 3.78B | 612.52M | 23.55B | -698.84M | -16.02B | -1.02B | 10.82B | 2.08B | 2.3B | 3.79B | 5.21B | 8.51B |
| Equity Issued (Net) | 3.4B | 3.5B | 1.13B | 1.16B | 874.29M | -2.77B | 1.85B | 1.14B | 1.22B | 11.63B | 998.51M | -4.2B | 1.52B | 4.4B | 311.63M | -2.23B | -636.12M | -1.04B | -888.92M | 1.01B | 851.54M | 330.45M | 41.09M | 0 | 0 | 0 | 4.15B | 0 |
| Dividends Paid | -96.19B | -23.16B | -22.92B | -37.34B | -30.36B | -17.91B | -8.13B | -10.5B | -10.81B | -11.12B | -12.28B | -15.86B | -10.1B | -7.72B | -4.19B | -3.95B | -1.8B | -2.5B | -9.13B | -6.87B | 0 | -404.39M | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -208.14M | -5.48B | 0 | 0 | -72.64M | 0 | 0 | -5.53B | 0 | 0 | 0 | -2.84B | -1.1B | -1.28B | -1.14B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 279.86B | -2.23B | -1.56B | -1.12B | -1.05B | -920.92M | -794.24M | -641.13M | -115.99M | 43.4M | 220.53M | 165.06M | -2.92M | -118.56M | 3.54B | -49.43M | 230.2M | 235.24M | 814.91M | -1.85B | 2.56B | 992.24M | -2.05B | 2.12B | -1.74B | -3.18B | 8.22B | 206.42M |
| Net Change in Cash | -1.5B | 19.1B | 4.62B | 9.35B | -25.99B | 25.32B | -4.82B | 10.08B | 3.92B | 10.78B | -15.87B | 1.52B | 3.84B | 24.03B | 6.71B | -1.47B | -533.68M | 3.22B | 1.57B | -1.19B | 13.51B | 0 | 0 | -1.27B | -1.39B | -2.4B | 2.36B | 3.7B |
| Free Cash Flow | -241.27B | -20.01B | 2.97B | 51.09B | 30.98B | 7.62B | 10.19B | 9B | 9.52B | 22.77B | 24.41B | 23.96B | 5.52B | 11.89B | -5.95B | 2.08B | 2.72B | 4.43B | 11.46B | 11.05B | 16.81B | 4.96B | -8.68B | -4.22B | -1.35B | 141.5M | -12.42B | -2.32B |
| FCF Margin % | -33.76% | -3.08% | 0.49% | 8.9% | 4.56% | 1.35% | 2.24% | 2.2% | 2.52% | 7.9% | 8.86% | 8.16% | 2.12% | 5.49% | -3.11% | 1.1% | 1.55% | 5.31% | 11.73% | 11.03% | 16.68% | 5.76% | -12.01% | -7.38% | -2.95% | 0.37% | -24.4% | -6.99% |
| FCF Growth % | -1145.13% | -774.83% | -94.2% | 64.87% | 306.45% | -25.16% | 13.17% | -5.43% | -58.2% | -6.71% | 1.87% | 334.33% | -53.59% | 299.92% | -386.29% | -23.61% | -38.61% | -61.37% | 3.71% | -34.25% | 238.83% | 157.15% | -105.56% | -213.48% | -1052.13% | 101.14% | -435.32% | - |
| FCF per Share | -107.10 | -9.03 | 1.35 | 23.50 | 14.33 | 3.49 | 4.75 | 4.22 | 4.48 | 10.88 | 11.78 | 11.62 | 2.68 | 6.14 | -3.14 | 1.06 | 1.43 | 2.43 | 6.01 | 5.65 | 8.64 | 2.75 | -4.63 | -2.46 | -0.70 | 0.08 | -8.78 | -1.90 |
| FCF Conversion (FCF/Net Income) | -3.95x | 3.50x | 2.56x | 3.34x | 1.67x | 1.24x | 2.64x | 3.93x | 2.01x | 2.07x | 2.35x | 2.74x | 1.91x | 2.63x | 2.53x | 2.29x | 2.02x | 2.37x | 4.82x | 2.33x | 1.94x | -4.36x | 4.60x | 4.85x | 87.67x | -5.46x | 3.02x | 0.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.89B | 1.52B | 1.39B | 1.66B | 1.72B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.08B | 2.9B | 2.11B | 1.34B | 1.54B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ASX stock.
ASE Technology Holding Co., Ltd. (ASX) generated $143.03B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
ASE Technology Holding Co., Ltd. (ASX) reported negative free cash flow of $20.01B in 2025, indicating capital requirements exceeded cash from operations.
ASE Technology Holding Co., Ltd. (ASX) spent $162.15B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, ASE Technology Holding Co., Ltd. (ASX) returned $23.16B to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Capex intensity and margin dilution
Cash Conversion Diverges from Net Income
In 2026Q2, operating cash flow of $47.0B was 2.23 times net income of $21.1B, per the latest quarterly report, indicating high earnings quality despite heavy capex.
The OCF/NI ratio has consistently exceeded 2.0 in recent quarters, suggesting that reported net income is backed by strong cash generation, likely due to significant non-cash depreciation and amortization. However, the 2025Q4 quarter showed a negative OCF/NI of -0.37, which appears anomalous and may reflect working capital timing or one-off items. Investors should monitor whether this ratio remains elevated as capex accelerates.
FCF Turns Negative on Capex Surge
Free cash flow swung to -$32.8B in 2026Q2 from -$10.0B in 2026Q1, as capex reached 41.8% of revenue, according to reported figures, signaling aggressive investment.
The FCF margin deteriorated to -17.2% in 2026Q2, the worst in the series, driven by a sharp increase in capital expenditures to $79.8B. This aligns with the company's strategic pivot toward advanced packaging for AI, but it means that despite strong operating cash flow, the company is currently burning cash. The trajectory suggests that FCF will remain negative in the near term as capex intensity stays elevated, which may pressure liquidity if not offset by financing.
Capex Intensity Signals Growth Bet
Capital expenditure as a percentage of revenue jumped to 41.8% in 2026Q2 from 20.5% in 2024Q4, per financial statements, indicating a significant shift toward growth-oriented investment.
The capex-to-revenue ratio has more than doubled over the past year, with the absolute spend reaching $79.8B in 2026Q2. This appears to be directed at advanced packaging capacity for AI and HPC applications, as noted in recent context. While this may support future revenue growth, it also raises the risk of overcapacity if demand softens, and the high fixed-cost nature of the business means that underutilization could compress margins. The depreciation charge of $20.0B in 2026Q2 is rising, but it still lags the pace of capex, suggesting that future depreciation will increase and further pressure earnings.
Working Capital Volatility Masks Core Trends
Working capital changes swung from -$52.9B in 2025Q3 to +$1.4B in 2026Q2, based on reported cash flow data, indicating lumpy cash flow timing.
The working capital line has been highly volatile, with large negative changes in 2025Q3 and positive changes in other quarters. This may reflect the pass-through nature of materials in the EMS segment, which can distort cash flow timing. The recent positive changes in 2026Q1 and Q2 suggest that the company is managing collections and payables effectively, but the volatility warrants caution when interpreting quarterly cash flow trends. Investors should focus on the longer-term average to assess underlying working capital efficiency.
Capital Deployment Focused on Expansion
Dividends and buybacks were minimal in 2026, with only $2.5B in dividends paid in 2025Q4, while acquisitions totaled $1.1B in 2026Q1, per cash flow data, indicating reinvestment.
The company appears to be prioritizing capital expenditure over shareholder returns, with no buybacks in the last ten quarters and only sporadic dividend payments. The $98.7B dividend outflow in 2025Q3 is notable, but it may be a one-time distribution. The lack of consistent returns suggests that management is reinvesting heavily in growth, which aligns with the AI-driven capex strategy. However, if the investment does not generate expected returns, shareholders may see limited cash returns in the near term.
Cumulative Earnings Outpace Cash Flow
Over the last ten quarters, cumulative net income of $108.7B exceeds cumulative operating cash flow of $469.6B, per reported data, but the gap is driven by massive capex.
While operating cash flow has been robust, the cumulative free cash flow is deeply negative due to the extraordinary capital expenditure program. This divergence between earnings and free cash flow is a critical signal: the company is reinvesting heavily to capture future growth, but it is currently consuming cash. The sustainability of this strategy depends on the success of the advanced packaging investments. If they fail to generate adequate returns, the company may face cash flow strain, especially given the debt/equity ratio of 0.71.
What the Cash Flow Statement Obscures
The cash flow statement may understate true cash generation due to the pass-through nature of EMS materials and potential capitalization of costs, per industry norms, warranting scrutiny.
The EMS segment's pass-through revenue can inflate operating cash flow without contributing to profitability, potentially masking underlying cash generation quality. Additionally, the depreciation schedule for packaging equipment may be extended, which could overstate operating cash flow relative to actual replacement needs. Investors should examine the footnotes for capitalized costs and the useful life assumptions to assess whether reported cash flow is sustainable.